Table 1.

Treatment groups.

		Treatment	Pooled groups	Primary vaccination schedule			Booster
Name of the group		Group	(primary objective)	Co-administered vaccines	Staggered vaccination*	N	18 months of age	N
R	R1	RTS,S/AS01 + PHiD-CV	Pooled RTS,S/AS01 groups (N = 425)	RTS,S/AS01 + DTaP/Hib + tOPV + PHiD-CV	HRV	142	DTaP/Hib + PHiD-CV	425
	R2	RTS,S/AS01 + HRV		RTS,S/AS01 + DTaP/Hib + tOPV + HRV	PHiD-CV	142
	R3	RTS,S/AS01 alone		RTS,S/AS01 + DTaP/Hib + tOPV	PHiD-CV + HRV	141
C	C1	HBV + PHiD-CV	Pooled HBV groups (N = 280)	HBV + DTaP/Hib + tOPV + PHiD-CV	HRV	141	DTaP/Hib + PHiD-CV	280
	C2	HBV + HRV		HBV + DTaP/Hib + tOPV + HRV	PHiD-CV	139

N = number of participants in the Total Vaccinated cohort. DTaP/Hib = Infanrix Hib, tOPV = trivalent oral polio vaccine, HRV = human rotavirus vaccine (Rotarix), PHiD-CV = 10-valent pneumococcal conjugate vaccine (Synflorix), HBV = hepatitis B vaccine (Engerix B).

^*Staggered administration of the indicated vaccine i.e., given 2 weeks after administration of the other vaccines.